| Name | Gunagratinib |
|---|
| Description | Gunagratinib (ICP-192) is a low toxicity and orally active pan-FGFR (fibroblast growth factor receptors) inhibitor that potently and selectively inhibits FGFR activities irreversibly by covalent binding. Gunagratinib can be used for the research of cancer[1]. |
|---|---|
| Related Catalog | |
| Target |
FGFR |
| In Vitro | Gunagratinib (ICP-192) is a low toxicity and orally active pan-FGFR (fibroblast growth factor receptors) inhibitor that potently and selectively inhibits FGFR activities irreversibly by covalent binding[1]. |
| References |
| Molecular Formula | C22H25N5O4 |
|---|---|
| Molecular Weight | 423.47 |